FDA's Janet Woodcock Addresses Sunscreen TEA 'Turmoil'
This article was originally published in The Rose Sheet
At a CHPA conference in Washington, the CDER director offered perspective on the center’s work on OTC drug monograph modernization and sunscreen ingredient TEAs. Marketing experience in foreign countries means only that a sunscreen ingredient may be eligible for GRASE consideration, she emphasized.
You may also be interested in...
So full of errors were the firm's online ads for its Plavinol supplement, the National Advertising Division noted support for some claims contained "many of the same flaws" as others. The prevalence of problems prompted NAD to go outside its "scope of review" and note unclear instructions on Plavinol labels.
Perrigo "walked away a little bit" from "a model that worked beautifully," says CEO Murray Kessler at investor conference, "In essence, all we've done over the last year is to put back in place the model that worked so well."